HAYDEN, Michael;TEVA PHARMACEUTICAL INDUSTRIES LTD.;AMIT-ROMACH, Einat;HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.;ILAN, Yaron;ROMAN, Doina, Cosma
Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepaiitis (NASH), including those also suffering from type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.L'invention concerne des méthodes de traitement de patients atteints de la maladie du foie gras non alcoolique (NAFLD) et de la stéatohépatite non alcoolique (NASH), notamment ceux atteints de diabète sucré de type II (T2DM), avec une composition pharmaceutique à libération retardée comprenant de la 6-mercaptopurine.
